Compound Astragalus and Salvia miltiorrhiza Extract Suppresses Rabbits' Hypertrophic Scar by Modulating the TGF-[beta]/Smad Signal

Background: Hypertrophic scar is a fibro-proliferative disease. Our previous studies demonstrate that compound Astragalus and Salvia miltiorrhiza extract (CASE) inhibits proliferation and invasion in keloid fibroblasts. Objective: To investigate the effects of CASE on hypertrophic scar. Methods: Rab...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dermatology (Basel) 2014-12, Vol.229 (4), p.363
Hauptverfasser: Wu, Chao, Jiang, Jiemei, Boye, Alex, Jiang, Yufeng, Yang, Yan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page 363
container_title Dermatology (Basel)
container_volume 229
creator Wu, Chao
Jiang, Jiemei
Boye, Alex
Jiang, Yufeng
Yang, Yan
description Background: Hypertrophic scar is a fibro-proliferative disease. Our previous studies demonstrate that compound Astragalus and Salvia miltiorrhiza extract (CASE) inhibits proliferation and invasion in keloid fibroblasts. Objective: To investigate the effects of CASE on hypertrophic scar. Methods: Rabbits were divided into the control, model and three dosage groups of CASE (0.94, 1.88, 3.76%). An animal model of hypertrophic scar was established and treated with CASE ointment or ointment base. The histopathological detection by hematoxylin & eosin and Masson's trichrome staining and protein expression of scars by Western blot were performed. Results: The hydroxyproline content was decreased under CASE treatment. Transforming growth factor beta 1 (TGF-β1) protein expression increased in the model group while it decreased under CASE treatment. The elevated expression of Smad4 protein was decreased under CASE treatment. Additionally, CASE promoted Smad7 protein expression. Conclusion: CASE could inhibit formation of hypertrophic scar by modulating TGF-β/Smad signal and may be useful for the treatment of hyperplastic scars. © 2014 S. Karger AG, Basel
doi_str_mv 10.1159/000365784
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1652374398</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3584019991</sourcerecordid><originalsourceid>FETCH-proquest_journals_16523743983</originalsourceid><addsrcrecordid>eNqNz71OwzAUBWALgUQpDLzBlRiYQuP8Z0RVfxYW0q1C1U1qEldObHxtRBl5cjzwAEz3HOmTji5j9zx-4jyvF3Ecp0VeVtkFm_Es4VFdpcllyDGvoqoo8mt2Q3QKLKnKesZ-lno02k9HeCZnsUflCTDUBtWnRBilclJbO8hvhNVXIJ2DxhtjBZEgeMW2lY4eYXs2wjqrzSA7aDq00J7hRR-9QienHtwgYLdZR_tWOHxbNCOGDdlPqG7Z1TsqEnd_d84e1qvdchsZqz-8IHc4aW8DpAMv8iQtszQ89T_1C-ssViM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1652374398</pqid></control><display><type>article</type><title>Compound Astragalus and Salvia miltiorrhiza Extract Suppresses Rabbits' Hypertrophic Scar by Modulating the TGF-[beta]/Smad Signal</title><source>Karger Journals</source><creator>Wu, Chao ; Jiang, Jiemei ; Boye, Alex ; Jiang, Yufeng ; Yang, Yan</creator><creatorcontrib>Wu, Chao ; Jiang, Jiemei ; Boye, Alex ; Jiang, Yufeng ; Yang, Yan</creatorcontrib><description>Background: Hypertrophic scar is a fibro-proliferative disease. Our previous studies demonstrate that compound Astragalus and Salvia miltiorrhiza extract (CASE) inhibits proliferation and invasion in keloid fibroblasts. Objective: To investigate the effects of CASE on hypertrophic scar. Methods: Rabbits were divided into the control, model and three dosage groups of CASE (0.94, 1.88, 3.76%). An animal model of hypertrophic scar was established and treated with CASE ointment or ointment base. The histopathological detection by hematoxylin &amp; eosin and Masson's trichrome staining and protein expression of scars by Western blot were performed. Results: The hydroxyproline content was decreased under CASE treatment. Transforming growth factor beta 1 (TGF-β1) protein expression increased in the model group while it decreased under CASE treatment. The elevated expression of Smad4 protein was decreased under CASE treatment. Additionally, CASE promoted Smad7 protein expression. Conclusion: CASE could inhibit formation of hypertrophic scar by modulating TGF-β/Smad signal and may be useful for the treatment of hyperplastic scars. © 2014 S. Karger AG, Basel</description><identifier>ISSN: 1018-8665</identifier><identifier>EISSN: 1421-9832</identifier><identifier>DOI: 10.1159/000365784</identifier><language>eng</language><publisher>Basel: S. Karger AG</publisher><subject>Dermatology ; Experiments ; Rabbits ; Skin diseases ; Studies</subject><ispartof>Dermatology (Basel), 2014-12, Vol.229 (4), p.363</ispartof><rights>Copyright (c) 2014 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Wu, Chao</creatorcontrib><creatorcontrib>Jiang, Jiemei</creatorcontrib><creatorcontrib>Boye, Alex</creatorcontrib><creatorcontrib>Jiang, Yufeng</creatorcontrib><creatorcontrib>Yang, Yan</creatorcontrib><title>Compound Astragalus and Salvia miltiorrhiza Extract Suppresses Rabbits' Hypertrophic Scar by Modulating the TGF-[beta]/Smad Signal</title><title>Dermatology (Basel)</title><description>Background: Hypertrophic scar is a fibro-proliferative disease. Our previous studies demonstrate that compound Astragalus and Salvia miltiorrhiza extract (CASE) inhibits proliferation and invasion in keloid fibroblasts. Objective: To investigate the effects of CASE on hypertrophic scar. Methods: Rabbits were divided into the control, model and three dosage groups of CASE (0.94, 1.88, 3.76%). An animal model of hypertrophic scar was established and treated with CASE ointment or ointment base. The histopathological detection by hematoxylin &amp; eosin and Masson's trichrome staining and protein expression of scars by Western blot were performed. Results: The hydroxyproline content was decreased under CASE treatment. Transforming growth factor beta 1 (TGF-β1) protein expression increased in the model group while it decreased under CASE treatment. The elevated expression of Smad4 protein was decreased under CASE treatment. Additionally, CASE promoted Smad7 protein expression. Conclusion: CASE could inhibit formation of hypertrophic scar by modulating TGF-β/Smad signal and may be useful for the treatment of hyperplastic scars. © 2014 S. Karger AG, Basel</description><subject>Dermatology</subject><subject>Experiments</subject><subject>Rabbits</subject><subject>Skin diseases</subject><subject>Studies</subject><issn>1018-8665</issn><issn>1421-9832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNz71OwzAUBWALgUQpDLzBlRiYQuP8Z0RVfxYW0q1C1U1qEldObHxtRBl5cjzwAEz3HOmTji5j9zx-4jyvF3Ecp0VeVtkFm_Es4VFdpcllyDGvoqoo8mt2Q3QKLKnKesZ-lno02k9HeCZnsUflCTDUBtWnRBilclJbO8hvhNVXIJ2DxhtjBZEgeMW2lY4eYXs2wjqrzSA7aDq00J7hRR-9QienHtwgYLdZR_tWOHxbNCOGDdlPqG7Z1TsqEnd_d84e1qvdchsZqz-8IHc4aW8DpAMv8iQtszQ89T_1C-ssViM</recordid><startdate>20141201</startdate><enddate>20141201</enddate><creator>Wu, Chao</creator><creator>Jiang, Jiemei</creator><creator>Boye, Alex</creator><creator>Jiang, Yufeng</creator><creator>Yang, Yan</creator><general>S. Karger AG</general><scope>3V.</scope><scope>7RV</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20141201</creationdate><title>Compound Astragalus and Salvia miltiorrhiza Extract Suppresses Rabbits' Hypertrophic Scar by Modulating the TGF-[beta]/Smad Signal</title><author>Wu, Chao ; Jiang, Jiemei ; Boye, Alex ; Jiang, Yufeng ; Yang, Yan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_16523743983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Dermatology</topic><topic>Experiments</topic><topic>Rabbits</topic><topic>Skin diseases</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Chao</creatorcontrib><creatorcontrib>Jiang, Jiemei</creatorcontrib><creatorcontrib>Boye, Alex</creatorcontrib><creatorcontrib>Jiang, Yufeng</creatorcontrib><creatorcontrib>Yang, Yan</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Dermatology (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Chao</au><au>Jiang, Jiemei</au><au>Boye, Alex</au><au>Jiang, Yufeng</au><au>Yang, Yan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Compound Astragalus and Salvia miltiorrhiza Extract Suppresses Rabbits' Hypertrophic Scar by Modulating the TGF-[beta]/Smad Signal</atitle><jtitle>Dermatology (Basel)</jtitle><date>2014-12-01</date><risdate>2014</risdate><volume>229</volume><issue>4</issue><spage>363</spage><pages>363-</pages><issn>1018-8665</issn><eissn>1421-9832</eissn><abstract>Background: Hypertrophic scar is a fibro-proliferative disease. Our previous studies demonstrate that compound Astragalus and Salvia miltiorrhiza extract (CASE) inhibits proliferation and invasion in keloid fibroblasts. Objective: To investigate the effects of CASE on hypertrophic scar. Methods: Rabbits were divided into the control, model and three dosage groups of CASE (0.94, 1.88, 3.76%). An animal model of hypertrophic scar was established and treated with CASE ointment or ointment base. The histopathological detection by hematoxylin &amp; eosin and Masson's trichrome staining and protein expression of scars by Western blot were performed. Results: The hydroxyproline content was decreased under CASE treatment. Transforming growth factor beta 1 (TGF-β1) protein expression increased in the model group while it decreased under CASE treatment. The elevated expression of Smad4 protein was decreased under CASE treatment. Additionally, CASE promoted Smad7 protein expression. Conclusion: CASE could inhibit formation of hypertrophic scar by modulating TGF-β/Smad signal and may be useful for the treatment of hyperplastic scars. © 2014 S. Karger AG, Basel</abstract><cop>Basel</cop><pub>S. Karger AG</pub><doi>10.1159/000365784</doi></addata></record>
fulltext fulltext
identifier ISSN: 1018-8665
ispartof Dermatology (Basel), 2014-12, Vol.229 (4), p.363
issn 1018-8665
1421-9832
language eng
recordid cdi_proquest_journals_1652374398
source Karger Journals
subjects Dermatology
Experiments
Rabbits
Skin diseases
Studies
title Compound Astragalus and Salvia miltiorrhiza Extract Suppresses Rabbits' Hypertrophic Scar by Modulating the TGF-[beta]/Smad Signal
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T07%3A20%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Compound%20Astragalus%20and%20Salvia%20miltiorrhiza%20Extract%20Suppresses%20Rabbits'%20Hypertrophic%20Scar%20by%20Modulating%20the%20TGF-%5Bbeta%5D/Smad%20Signal&rft.jtitle=Dermatology%20(Basel)&rft.au=Wu,%20Chao&rft.date=2014-12-01&rft.volume=229&rft.issue=4&rft.spage=363&rft.pages=363-&rft.issn=1018-8665&rft.eissn=1421-9832&rft_id=info:doi/10.1159/000365784&rft_dat=%3Cproquest%3E3584019991%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1652374398&rft_id=info:pmid/&rfr_iscdi=true